MedTrace Logo

RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis

NCT06838624 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-02-24

No results posted yet for this study

Summary

The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are:

* Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients.
* Compare the outcomes of Redcord treatment with standard care practices.

Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.

Conditions

Interventions

DEVICE

Redcord

Perticipants will perform exercises in different plank positions using RedCord® while applying local vibration in: * Supine plank position * Prone plank position * Lateral prone plank position

OTHER

Control (Standard treatment)

Participants will perform exercises in different plank positions: Supine plank position Prone plank position Lateral prone plank position

Sponsors & Collaborators

  • University of Castilla-La Mancha

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-09-30
Completion
2026-12-15

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06838624 on ClinicalTrials.gov